We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$433M
AUM Growth
-$2.26M
Cap. Flow
-$41.6M
Cap. Flow %
-9.6%
Top 10 Hldgs %
72.23%
Holding
30
New
2
Increased
5
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$24.4M
2
CTLT
CATALENT, INC.
CTLT
+$17.9M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$17.8M
4
NTRA icon
Natera
NTRA
+$9.02M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$1.07M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$28.7M
2
AZN icon
AstraZeneca
AZN
+$20.7M
3
ILMN icon
Illumina
ILMN
+$16M
4
CANO
Cano Health, Inc.
CANO
+$8.83M
5
AMWL icon
American Well
AMWL
+$8.06M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$40B
$41.8M 9.65%
204,095
+4,200
+2% +$852K
ALNY icon
2
Alnylam Pharmaceuticals
ALNY
$29B
$37M 8.54%
155,716
-6,000
-4% -$1.28M
UTHR icon
3
United Therapeutics
UTHR
$22.7B
$36.5M 8.42%
131,238
-9,500
-7% -$2.4M
NTRA icon
4
Natera
NTRA
$46.4B
$32.7M 7.55%
814,994
+219,000
+37% +$9.02M
OM icon
5
Outset Medical
OM
$94M
$31.5M 7.27%
81,374
-1,159
-1% -$327K
ISRG icon
6
Intuitive Surgical
ISRG
$138B
$28.7M 6.63%
108,230
-13,400
-11% -$3.27M
ILMN icon
7
Illumina
ILMN
$29B
$27.9M 6.43%
141,776
-77,395
-35% -$16M
TNDM icon
8
Tandem Diabetes Care
TNDM
$1.57B
$26.5M 6.12%
590,500
+394,100
+201% +$17.8M
INSP icon
9
Inspire Medical Systems
INSP
$1.73B
$25.6M 5.9%
101,543
+990
+1% +$211K
DXCM icon
10
DexCom
DXCM
$33.2B
$24.8M 5.72%
219,000
-46,800
-18% -$5.14M
ICLR icon
11
Icon
ICLR
$12.9B
$23.9M 5.52%
+123,100
New +$24.4M
ARGX icon
12
argenx
ARGX
$54.2B
$22.8M 5.27%
60,300
– –
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
$22.5M 5.19%
174,902
– –
CTLT
14
DELISTED
CATALENT, INC.
CTLT
$14.8M 3.42%
+329,100
New +$17.9M
FDMT icon
15
4D Molecular Therapeutics
FDMT
$572M
$9.73M 2.24%
437,911
+69,500
+19% +$1.07M
AGIO icon
16
Agios Pharmaceuticals
AGIO
$1.94B
$7.52M 1.73%
267,630
-62,083
-19% -$1.75M
ADPT icon
17
Adaptive Biotechnologies
ADPT
$4.09B
$4.64M 1.07%
607,860
-607,000
-50% -$4.72M
AMWL icon
18
American Well
AMWL
$232M
$3.95M 0.91%
69,752
-111,834
-62% -$8.06M
CMAX
19
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$2.61M 0.6%
23,825
– –
GH icon
20
Guardant Health
GH
$22.8B
$1.81M 0.42%
66,560
-85,400
-56% -$3.91M
TXG icon
21
10x Genomics
TXG
$7.47B
$1.79M 0.41%
49,200
– –
BEAM icon
22
Beam Therapeutics
BEAM
$2.82B
$1.13M 0.26%
28,900
– –
OLK
23
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.02M 0.23%
40,000
– –
ARVN icon
24
Arvinas
ARVN
$585M
$787K 0.18%
23,000
– –
BCYC
25
Bicycle Therapeutics
BCYC
$287M
$696K 0.16%
23,500
– –
1
2

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Eagle Health Investments held 30 positions worth $433M, down 0.52% from $436M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Eagle Health Investments withdrew a net $41.6M in Q4 2022, closing 3 positions and reducing 11 holdings. Its most notable exit was Humana, an estimated $28.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Eagle Health Investments opened a new position in Icon worth $23.9M.

  • Eagle Health Investments's largest Q4 2022 buy was Icon: 123,100 shares worth $23.9M.
  • Eagle Health Investments added most to Tandem Diabetes Care in Q4 2022, an estimated $17.8M increase.
  • Eagle Health Investments's biggest Q4 2022 reduction was Illumina, cutting an estimated $16M.
  • Eagle Health Investments fully exited Humana in Q4 2022, selling an estimated $28.7M.
  • Eagle Health Investments's ten largest holdings make up 72% of its $433M portfolio in Q4 2022.
  • Eagle Health Investments opened 2 new positions and closed 3 in Q4 2022.
  • Eagle Health Investments's portfolio value fell 0.52% quarter-over-quarter to $433M.

Based on Eagle Health Investments's 13F filing for Q4 2022, filed 13 Feb 2023.